Prostate DWI
Daniel Margolis1

1Department of Radiology, Weill Cornell Medical College, New York, NY, United States

Synopsis

Diffusion-weighted imaging has gone from being a research tool to a correlate of cancer aggressiveness to a mainstay in routine prostate magnetic resonance imaging. From the basic components required for clinically useful imaging, to esoteric and technically demanding pulse sequences that tantalize us with the potential of obviating tissue diagnosis, diffusion-weighted imaging of the prostate runs the gamut from the mundane to the sublime.

Prostate Diffusion Weighted Imaging

Diffusion-weighted imaging, as a component of magnetic resonance imaging of the prostate, began as a research tool, proved to correlate with cancer aggressiveness, and has become a core component of prostate cancer management in the past 15 years. From the basics of prostate magnetic resonance imaging required for adequate image quality in clinical use, to advanced, technically demanding methods that tantalize with the potential to obviate tissue diagnosis, diffusion weighted imaging pervades the characterization of prostate cancer in modern practice.

Acknowledgements

The speaker would like to thank the ISMRM, the meeting president Scott Reeder, his colleagues at Cornell and Memorial Sloan Kettering (especially Lorenzo Mannelli), and the Stanford Radiological Sciences laboratory and Roland Bammer, who gave him his start with prostate DWI

References

  1. Hope TR, White NS, Kuperman J, Chao Y, Yamin G, Bartch H, Schenker-Ahmed NM, Rakow-Penner R, Bussell R, Nomura N, Kesari S, Bjørnerud A, Dale AM. Demonstration of Non-Gaussian Restricted Diffusion in Tumor Cells Using Diffusion Time-Dependent Diffusion-Weighted Magnetic Resonance Imaging Contrast. Front Oncol. 2016 Aug 2;6:179.
  2. Jambor I, Merisaari H, Aronen HJ, Järvinen J, Saunavaara J, Kauko T, Borra R, Pesola M. Optimization of b-value distribution for biexponential diffusion-weighted MR imaging of normal prostate. J Magn Reson Imaging. 2014 May;39(5):1213-22.
  3. Donati OF, Mazaheri Y, Afaq A, Vargas HA, Zheng J, Moskowitz CS, Hricak H, Akin O. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Radiology. 2014 Apr;271(1):143-52
  4. Rosenkrantz AB, Prabhu V, Sigmund EE, Babb JS, Deng FM, Taneja SS. Utility of diffusional kurtosis imaging as a marker of adverse pathologic outcomes among prostate cancer active surveillance candidates undergoing radical prostatectomy. AJR Am J Roentgenol. 2013 Oct;201(4):840-6
  5. Finley DS, Ellingson BM, Natarajan S, Zaw TM, Raman SS, Schulam P, Reiter RE, Margolis D. Diffusion tensor magnetic resonance tractography of the prostate: feasibility for mapping periprostatic fibers. Urology. 2012 Jul;80(1):219-23
  6. Eiber M, Beer AJ, Holzapfel K, Tauber R, Ganter C, Weirich G, Krause BJ, Rummeny EJ, Gaa J. Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging. Invest Radiol. 2010 Jan;45(1):15-23.
  7. deSouza NM, Riches SF, Vanas NJ, Morgan VA, Ashley SA, Fisher C, Payne GS, Parker C. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol. 2008 Jul;63(7):774-82
  8. Mulkern RV, Barnes AS, Haker SJ, Hung YP, Rybicki FJ, Maier SE, Tempany CM. Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. Magn Reson Imaging. 2006 Jun;24(5):563-8
  9. Pickles MD, Gibbs P, Sreenivas M, Turnbull LW. Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T. J Magn Reson Imaging. 2006 Feb;23(2):130-4
  10. Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging. 2002 Aug;16(2):196-200
Proc. Intl. Soc. Mag. Reson. Med. 25 (2017)